The global research antibodies market size is calculated at USD 5,390 million in 2024 and is predicted to reach around USD 11,840 million by 2034, expanding at a CAGR of 8.2% from 2024 to 2034.
key reasons fueling the growth of the market for research antibodies is the increase in demand for high-quality antibodies for reproducible research. The market is also witnessing growth due to the expanding landscape of proteomics and genomics research as well as increased research and development efforts in the life sciences domain. Furthermore, the market is also influenced by the rise of industry-academia partnerships as well as the expanding stem cell research and neurobiology research fields to provide for the unmet medical needs across the globe. Furthermore, the increase in geriatric population and a dearth of remedies for chronic diseases have also contributed to a sharp increase in demand for research antibodies to create customized medicines, cutting-edge pharmaceuticals, and novel & effective treatments. However, high cost associated with research antibodies and nontherapeutic antibodies quality concern is hindering markets growth.
Although, an increase in funding for research initiatives from for-profit and nonprofit groups, as well as rising focus on biomarker development and outsourcing interests is driving the market growth. Moreover, the growing demand for protein therapies and personalized medicine are opening new market opportunities and present lucrative growth prospects for the research antibodies market players over the forecast period.
Published by Ajit Bansod
